Apellis Pharmaceuticals, Inc. (APLS) Reports Q4 Loss, Tops Revenue Estimates
28/2 23:45
Apellis Pharmaceuticals, Inc. (APLS) came out with a quarterly loss of $1.61 per share versus the Zacks Consensus Estimate of a loss of $1.32. This compares to earnings of $0.93 per share a year ago. These figures are adjusted for non-recurring items....